Table 1.
Study | Patients (n) | Stage | Treament (Gy) | 3-to 5-year OS (%) | 3-to 5-year LCR (%) |
---|---|---|---|---|---|
Moonen et al. (1998) | 379 | T1G3-T3a | RT alone 50-75 Gy | 40.3 | |
Piet et al. (2008) | 92 | T2-T4 | RT alone 55 Gy | 36 | 56 |
Jenkins et al. (1988) | 182 | T2-T3 | RT alone | 40 | |
Moonen et al. (1994) | 40 | T1G3-T3a | TUR + RT 30 Gy | 86 | 84 |
Yavuz et al. (2004) | 87 | T1-T4 | RT alone 67.5 Gy | 46 | 64 |
Horwich et al. (2005) | 229 | T2-T3 | AF (60.8 Gy) n = 129 | 54 VS. 47 | |
CF (64 Gy) n = 100 | 37 VS. 40 |
OS = overall survival, DSS = disease-specific survival, RT = radiotherapy, TUR = transurethral resection, AF = accelerated fractionation, CF = conventional fractionation.